Personal Genome Diagnostics Gets CE Mark for Elio Tissue Complete Assay, Published on Sep 25, 2019  Thermo Fisher Scientific Prices $5.7B Senior Notes Offering Published on Sep 25, 2019  DiaSorin Molecular Gets CE Mark for VZV Swab Direct Molecular Test Published on Sep 25, 2019  T2 Biosystems Inks Distribution Deal in Puerto Rico, US Virgin Islands Published on Sep 25, 2019

Featured in Depth

SkylineDx Partners With Mayo Clinic on Melanoma Risk Test Study Ahead of Planned US Trial Published on Sep 24, 2019

PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Published on Sep 23, 2019

Human Cell Atlas Builds Out Data Coordination Platform With Support From Chan Zuckerberg Initiative Published on Sep 23, 2019

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Published on Sep 23, 2019

Recommended for You

Aethlon Medical Lands $1.9M SBIR Grant for Exosome Isolation Device Published on Sep 16, 2019  SkylineDx Secures $21.9M Investment Published on Sep 03, 2019

The 'Dark Matter' of Cancer Genomics: Revealing Undetected Structural Variants in Leukemia This white paper is based on a webinar presentation by Dr. James Broach of the Penn State College of Medicine. He discussed methods for capturing a comprehensive snapshot of all variants — both point mutations and structural variants — present in a tumor sample in order to gain insights about the genetic and genomic basis of individual cancers. Download it from GenomeWeb’s White Paper Channel.